Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/18462730
Conclusion of this study
These data show that in patients with PCOS, treatment with myo-inositol and folic acid, but not folic acid alone, reduces germinal vesicles and degenerated oocytes at ovum pick-up without compromising total number of retrieved oocytes. This approach, reducing E(2) levels at hGC administration, could be adopted to decrease the risk of hyperstimulation in such patients.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study